Shanghai-Hong Kong Zhongke
Biopharmaceutical preclinical research and development service company
News Center
News Center
2022-12-19
ZSHK Debuts in BIOHK2022On 14 th December 2022, Hong Kong, China. ZSHK Laboratories Limited (ZSHK) participates in BIOHK2022. The exhibition was located at the Hong Kong Convention and Exhibition Centre, Wan Chai. The event was successfully held. As one of the exhi...
Read more +2022-11-28
Preclinical CRO Company ZSHK Announces Completion of Nearly ¥100 Million Series B FinancingOn 28th November 2022 , ZSHK Laboratories Limited (ZSHK) announces its completion of nearly ¥100 million series B financing. Such series of financing was led by AZ-CICC Healthcare Fund and followed by existing shareholdersAscendum Capital....
Read more +2022-11-11
ZSHK was Invited to the Second Asia Summit on Global HealthOn 10 th November 2022. Hong Kong China. The second Asia Summit on Global Health (ASGH) was staged grandly at theHong Kong Convention and Exhibition Centre by the Hong Kong Government and Hong Kong Trade Development Council. The summit was t...
Read more +2022-11-08
ZSHK Debuts in 2022 ShenZhen International Biotech & Health Industry Expo and BT SummitIn 3 rd to 4 th November 2022, ShenZhen, China, ZSHK Laboratories Limited (ZSHK) and its wholly-owned subsidiariesAnling Biomed (Shenzhen) Co. ,Ltd. (Anling (Shenzhen)) and Anling Biomed (Suzhou) Co. ,Ltd. (Anling (Suzhou)) were invited to 2...
Read more +2022-10-17
AnLing (ShenZhen) is Granted Full Accreditation from AAALACOctober 14, 2022. AnLing Biomedical (ShenZhen) Co., Ltd (hereinafter referred to as AnLing (ShenZhen)) has successfully been awarded FULL ACCREDITATION from the Association for Assessment and Accreditation of Laboratory Animal Care Internati...
Read more +